# Pharmacogenomic Data Submissions - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/pharmacogenomic-data-submissions/9a29ff18-0847-4eaa-b84e-2e4b7bd5d29e

> FDA guidance document: Pharmacogenomic Data Submissions. Issue date: March 17, 2023. Get complete insights and analysis.

---

## Details

- Title: Pharmacogenomic Data Submissions
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-03-17
- Comment Close Date: 2023-06-20
- Last Changed: 2023-03-23
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-2856">FDA-2022-D-2856</a>

## Related Documents

- [Establishing Impurity Specifications for Antibiotics](https://www.globalkeysolutions.net/guidances/guidance-document/establishing-impurity-specifications-for-antibiotics/5bb8badb-7c32-4b76-bfc9-bbb8ab55fb84)
- [Clinical Pharmacology Considerations for Peptide Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-pharmacology-considerations-for-peptide-drug-products/1609c8ed-4d50-4235-8a00-9c63176affe8)
- [Drug Master Files Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-master-files-guidance-for-industry/7dfd5140-3156-43f2-bdb9-d23ad597311c)